GENE ONLINE|News &
Opinion
Blog

2022-07-22|

Shifting From Counterculture to Clinical Applications, The Problems Psychedelics Face Getting to Market

by Reed Slater
Share To

The clinical application of psychedelics like MDMA, psilocybin, and LSD is gaining support daily. The class of drugs is quickly shedding its stigma as more research demonstrates the promise of treating ever-pervasive mental health disorders like depression, anxiety, and bipolar. Even with a growing acceptance, psychedelic therapies face significant challenges before they have a chance at making it to the market. 

At BIO International Convention in San Diego, five esteemed professionals in the field discussed the hurdles clinical psychedelic development faces before it can benefit the millions of people in need of better mental health treatments. The panel highlighted problems like scalability, clinical limitations, intellectual property issues, and overcoming the stigma of psychedelics.

GO Prime with only $1.49 now

LATEST
University of Pittsburgh Study Finds Flu Vaccines Prevent Up to 41.5 Percent of Infections in Simulated Communities
2025-07-19
Pharmacist-Led Initiatives Boost Pneumococcal Vaccine Uptake Among Older Adults Through Education and Direct Immunization Services
2025-07-19
Study Finds Agricultural Dust Exposure Alters Gut Microbiota and Weakens Intestinal Barrier in Mice
2025-07-19
Biotech Leaders Urge FDA to Reject Conservative Report Criticizing Mifepristone Safety Profile
2025-07-19
Physician Calls for Better Diagnosis of Cannabinoid Hyperemesis Syndrome Amid Discussions on Drug Pricing and Accessibility
2025-07-19
Maternal Vaccination Linked to Reduced RSV Hospitalizations in Newborns
2025-07-18
FDA Advisory Committee Votes Against Approval of GSK’s Blenrep Ahead of PDUFA Date
2025-07-18
EVENT
2025-07-23
BIO Asia–Taiwan 2025
Taipei, Taiwan
2025-08-08
HEALTHY AGEING TECH SHOW
Taipei, Taiwan
2025-08-09
MEDINFO 2025
Taipei, Taiwan
2025-09-03
BIO ASIA PACIFIC 2025
Bangkok, Thailand
2025-09-10
BIOHK 2025
Hong Kong
2025-10-01
Medical Japan 2025
Osaka, Japan
Scroll to Top